SYNERGISTIC CYTOTOXIC EFFECTS OF TUMOR-NECROSIS-FACTOR, INTERFERON-GAMMA AND TAMOXIFEN ON BREAST-CANCER CELL-LINES

被引:0
作者
MATSUO, S [1 ]
TAKANO, S [1 ]
YAMASHITA, J [1 ]
OGAWA, M [1 ]
机构
[1] KUMAMOTO UNIV,SCH MED,DEPT SURG 2,1-1-1 HONJO,KUMAMOTO 860,JAPAN
关键词
INTERFERON; TUMOR NECROSIS FACTOR; HUMAN BREAST CANCER CELL LINE; TAMOXIFEN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The combined effects of recombinant human tumor necrosis factor (TNF), interferon-gamma (IFN) and tamoxifen (TAM) on the proliferation of human breast cancer cell lines were investigated. In estrogen receptor positive MCF-7 cells, relatively resistant to TAM or TNF, cytotoxicity significantly increased in combinations of TNF and IFN, and of a cytokine and TAM. The cytotoxicity of TNF increased when cells were pretreated with IFN, but not vice versa. Sequential treatment with IFN following TNF and TAM also exhibited significant antiproliferative effect on both cell lines. The combined or sequential cytokines and TA M treatments are possible modalities to overcome breast cancers unresponsive to endocrine treatment.
引用
收藏
页码:1575 / 1580
页数:6
相关论文
共 24 条
[1]  
ABBRUZZESE JL, 1989, CANCER RES, V49, P4057
[2]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[3]  
BALKWILL FR, 1986, CANCER RES, V46, P3990
[4]  
BEZWODA WR, 1990, CANCER RES, V50, P5387
[5]  
BLICK M, 1987, CANCER RES, V47, P2986
[6]   DNA FRAGMENTATION AND CYTOTOXICITY CAUSED BY TUMOR-NECROSIS-FACTOR IS ENHANCED BY INTERFERON-GAMMA [J].
DEALTRY, GB ;
NAYLOR, MS ;
FIERS, W ;
BALKWILL, FR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (05) :689-693
[7]  
GOLDSTEIN D, 1989, CANCER RES, V49, P2698
[8]   RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS [J].
GUTTERMAN, JU ;
FINE, S ;
QUESADA, J ;
HORNING, SJ ;
LEVINE, JF ;
ALEXANIAN, R ;
BERNHARDT, L ;
KRAMER, M ;
SPIEGEL, H ;
COLBURN, W ;
TROWN, P ;
MERIGAN, T ;
DZIEWANOWSKI, Z .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :549-556
[9]  
HARANAKA K, 1981, JPN J EXP MED, V51, P191
[10]  
LEE SH, 1984, J IMMUNOL, V133, P1083